Immunosuppressive class and drug | ICTs (n) | ||
---|---|---|---|
Antimetabolite | 22 | ||
 | Azathioprine | 8 |  |
 | Hydroxycarbamide | 3 |  |
 | Leflunomide | 1 |  |
 | Mercaptopurine | 1 |  |
 | Methotrexate | 9 |  |
TNF Inhibitor | 7 | ||
 | Adalimumab | 5 |  |
 | Etanercept | 2 |  |
Steroids | 5 | ||
Anti-CD20 | 4 | ||
 | Rituximab | 4 |  |
Mycophenolate mofetil | 4 | ||
Calcineurin Inhibitor | 4 | ||
 | Sirolimus | 1 |  |
 | Tacrolimus | 3 |  |
α4-integrin inhibitor | 3 | ||
 | Natalizumab | 2 |  |
 | Vedolizumab | 1 |  |
Interferon therapy | 2 | ||
 | Peginterferon alfa-2a | 1 |  |
 | Interferon beta-1α | 1 |  |
BCR-ABL tyrosine kinase inhibitor | 1 | ||
 | Nilotinib | 1 |  |
Sphingosine 1-phosphate receptor modulator | 1 | ||
Anti-IL6 | 1 | ||
 | Tocilizumab | 1 |  |
CD30 Targeted Agent | 1 | ||
 | Brentuximab | 1 |  |
Co-stimulation modulator | 1 | ||
 | Abatacept | 1 |  |
IL-12, IL-23 Pathway Inhibitor | 1 | ||
 | Ustekinumab | 1 |  |
Total | 57 |